Ametek
AME
$221.78
-3.49%
Ametek, Inc. is a diversified industrial technology company operating in the Electrical Equipment & Parts industry, with a core business focused on manufacturing highly engineered electronic instruments and electromechanical components. The company has established a distinct competitive identity as a market leader in numerous niche industrial segments, operating through a decentralized model of over 40 autonomous businesses that emphasize product differentiation and operational excellence. The current investor narrative is centered on the company's demonstrated financial strength and commitment to shareholder returns, as evidenced by a recent 10% dividend increase, while ongoing debate likely focuses on its ability to sustain organic growth and margin expansion amidst a dynamic industrial cycle through its proven acquisition strategy.…
AME
Ametek
$221.78
Related headlines
Investment Opinion: Should I buy AME Today?
Rating & Thesis: Hold. Ametek is a high-quality industrial compounder with exceptional fundamentals, but its current valuation fully reflects this quality, limiting near-term upside and elevating risk. The analyst consensus leans cautiously optimistic to neutral, with an average EPS target of $9.91 implying growth but not necessarily significant price appreciation from current levels.
Supporting Evidence: The Hold rating is supported by four key data points: 1) A premium forward P/E of 25.96x versus likely sector averages in the mid-teens, 2) Robust but potentially peak revenue growth of 13.44% YoY, 3) Exceptional and stable profitability with a 26.2% operating margin, and 4) Strong shareholder returns evidenced by a 10% dividend increase and $1.67B in annual FCF for buybacks. The stock's high PEG ratio of 4.05 further signals limited margin of safety.
Risks & Conditions: The two biggest risks are a growth slowdown that triggers multiple compression and a broader market downturn affecting all premium valuations. This Hold rating would upgrade to a Buy if the forward P/E compresses meaningfully below 23x on sustained growth, or if a market pullback provides a better entry point. It would downgrade to Sell if quarterly revenue growth decelerates below 8% or operating margins show sustained contraction. The stock is currently fairly valued to slightly overvalued relative to its own history and sector peers, pricing in near-perfect execution.
Sign up to view all
AME 12-Month Price Forecast
The AI assessment is neutral based on a clash between stellar fundamentals and a fully valued stock price. Ametek's operational excellence is undeniable, but the market has already rewarded it handsomely, with the stock trading near its 52-week high at a premium multiple. The high PEG ratio of 4.05 is a significant warning sign. The base case of steady execution with limited multiple expansion is most probable. The stance would upgrade to bullish on a meaningful pullback (10-15%) that improves the risk/reward profile, or if evidence emerges of accelerating organic growth. It would turn bearish if quarterly results show margin erosion or growth deceleration below the high-single digits.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ametek's 12-month outlook, with a consensus price target around $288.31 and implied upside of +30.0% versus the current price.
Average Target
$288.31
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$177 - $288
Analyst target range
Analyst coverage for AME is moderate with 7 firms providing estimates, and recent institutional ratings show a mix of 'Outperform', 'Equal Weight', and 'Neutral' stances, with one notable downgrade from 'Outperform' to 'Perform' in January 2026, indicating a consensus that leans cautiously optimistic to neutral. The average revenue estimate for the upcoming period is $9.63 billion, with a range from $9.42 billion to $9.91 billion, and the average EPS estimate is $9.91, ranging from $9.63 to $10.29; this relatively tight range, coupled with the lack of 'Sell' ratings, suggests analysts have strong conviction in the company's near-term financial forecasts, though the wide dispersion in recent rating actions points to some debate over the stock's near-term upside potential.
Bulls vs Bears: AME Investment Factors
The bull case for Ametek is anchored in its demonstrable financial strength, characterized by exceptional profitability, robust cash generation, and consistent revenue growth. The bear case centers on a valuation that appears stretched, trading at peak historical multiples with a high PEG ratio, leaving the stock sensitive to any disappointment. Currently, the bearish arguments on valuation carry stronger evidence, as the stock's premium pricing demands near-perfect execution. The single most important tension in the investment debate is whether Ametek's superior margins and growth can sustainably justify its premium valuation multiple in the face of a potential industrial slowdown or rising interest rates.
Bullish
- Exceptional Profitability & Strong Margins: Ametek's operating margin of 26.2% and net margin of 20.0% are significantly above typical industrial company levels, demonstrating superior pricing power and operational efficiency. This is underpinned by a stable gross margin of approximately 36.9% in Q4 2025, reflecting the premium nature of its engineered products.
- Robust Revenue Growth Trajectory: The company delivered consistent sequential quarterly revenue growth in 2025, culminating in a 13.44% year-over-year increase in Q4 to $1.998 billion. This steady demand across its diversified portfolio indicates resilience and effective execution of its growth strategy.
- Fortress Balance Sheet & Strong Cash Flow: With a low debt-to-equity ratio of 0.215 and annual free cash flow generation of $1.672 billion, Ametek possesses exceptional financial flexibility. This provides ample internal resources for strategic acquisitions, share buybacks, and dividend growth, as evidenced by the recent 10% dividend hike.
- Analyst Conviction in Forward Earnings: The forward P/E of 25.96x is notably lower than the trailing P/E of 31.97x, signaling market expectations for significant earnings growth. Analyst consensus EPS for the upcoming period is $9.91, with a tight range from $9.63 to $10.29, indicating strong forecast confidence.
Bearish
- Premium Valuation at Peak Multiples: The stock's trailing P/E of 31.97x is at the upper end of its historical range and trades at a significant premium to typical industrial sector multiples. This high valuation leaves little room for error and increases vulnerability to multiple compression if growth expectations falter.
- Recent Momentum Divergence & Technical Resistance: Despite a strong 1-year uptrend of 29.09%, the stock is down 2.46% over the past month and underperforming the S&P 500 by 7.06% over the same period. Trading at 94% of its 52-week high of $243.18, it faces a critical technical resistance level where profit-taking may intensify.
- High PEG Ratio Suggests Overvaluation: The PEG ratio of 4.05 is exceptionally high, indicating the stock's price is not justified by its expected earnings growth rate. This metric suggests the market is already pricing in several years of flawless execution, creating a high bar for the company to meet.
- Mixed Analyst Sentiment & Rating Downgrade: While there are no 'Sell' ratings, analyst stances range from 'Outperform' to 'Neutral' and 'Equal Weight', with one notable downgrade from 'Outperform' to 'Perform' in January 2026. This indicates growing caution about the stock's near-term upside potential at current levels.
AME Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a robust 29.09% price appreciation, and is currently trading at approximately 94% of its 52-week high of $243.18, indicating strong momentum but also positioning it near a critical resistance level where profit-taking or consolidation may occur. Recent momentum, however, shows a divergence from the longer-term trend, with the stock down 2.46% over the past month and up only 3.05% over the past three months, suggesting a potential pause or pullback within the broader uptrend as the market digests gains. Key technical levels are clearly defined by the 52-week high of $243.18 and low of $174.43, with a breakout above resistance potentially signaling a new leg higher, while the stock's beta of 1.033 indicates its volatility is very closely aligned with the broader market, implying typical market-level risk for position sizing.
Beta
1.00
1.00x market volatility
Max Drawdown
-13.7%
Largest decline past year
52-Week Range
$174-$243
Price range past year
Annual Return
+23.3%
Cumulative gain past year
| Period | AME Return | S&P 500 |
|---|---|---|
| 1m | -4.5% | -1.9% |
| 3m | +2.9% | +8.9% |
| 6m | +9.9% | +6.4% |
| 1y | +23.3% | +20.3% |
| ytd | +6.0% | +6.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AME Fundamental Analysis
Revenue growth remains healthy, with Q4 2025 revenue of $1.998 billion representing a 13.44% year-over-year increase, and a sequential trend from Q1 to Q4 2025 showing consistent quarterly revenue growth from $1.732B to $1.998B, indicating a steady demand trajectory across its diversified portfolio. Profitability is robust, with Q4 net income of $398.6 million and a gross margin of 36.93%, and while the quarterly gross margin has fluctuated between 36.0% and 36.9% through 2025, it remains stable at a level indicative of the company's premium product positioning and pricing power. The balance sheet is exceptionally strong, with a low debt-to-equity ratio of 0.215, a current ratio of 1.062, and substantial annual free cash flow generation of $1.672 billion (TTM), providing ample internal resources for strategic acquisitions, share repurchases, and dividend growth without reliance on external financing.
Quarterly Revenue
$2.0B
2025-12
Revenue YoY Growth
+0.13%
YoY Comparison
Gross Margin
+0.36%
Latest Quarter
Free Cash Flow
$1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AME Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 31.97x, while the forward P/E is notably lower at 25.96x, indicating the market expects meaningful earnings growth in the coming year. Compared to sector averages, Ametek trades at a significant premium; for instance, its forward P/E of 25.96x is well above typical industrial multiples, a premium that is likely justified by its superior and consistent profitability metrics, such as a 26.2% operating margin and 20.0% net margin, which are exceptional for its industry. Historically, the stock's current trailing P/E of 31.97x is near the upper end of its own range over the past several quarters, which have typically fluctuated between the high-20s and low-30s, suggesting the market is currently pricing in optimistic expectations for continued execution.
PE
32.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 22x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ametek's primary financial risk is not leverage or liquidity, given its strong balance sheet (D/E of 0.215), but rather its dependence on sustaining high growth to justify its premium valuation. With a forward P/E of 25.96x and a PEG ratio of 4.05, any deceleration in its 13.4% YoY revenue growth or margin compression from its 26.2% operating margin level could trigger significant multiple contraction. The company's acquisition-driven growth model also carries integration and overpayment risks, though its strong $1.67B in annual FCF provides a cushion.
Market & Competitive Risks: The stock faces pronounced valuation compression risk, as its forward P/E of 25.96x is well above typical industrial multiples. A market rotation away from premium-priced quality names or a rise in interest rates could disproportionately impact AME. Its beta of 1.033 indicates it moves closely with the broader market, offering no defensive characteristics during downturns. Competitive risks are mitigated by its niche market leadership but persist from larger, more diversified industrial technology firms.
Worst-Case Scenario: The worst-case scenario involves a combination of an industrial recession, a failed large acquisition, and a broader market sell-off compressing growth stock multiples. This could lead to a simultaneous earnings miss and a derating of its P/E towards its historical lower range or sector averages. A realistic downside could see the stock retreat to its 52-week low of $174.43, representing a potential loss of approximately -24% from the current price of $228.76, exacerbated by its recent underperformance versus the market.
FAQ
The key risks are: 1) Valuation Risk: The primary risk is multiple compression if its high growth rate (13.4% YoY) decelerates, given its premium P/E and PEG ratios. 2) Economic & Market Risk: With a beta of 1.033, it lacks defensiveness in a downturn, and a recession could hurt its diverse end markets. 3) Execution Risk: Its acquisition-driven growth model carries integration and overpayment risks, though its strong balance sheet mitigates this. 4) Competitive Risk: While it leads in niches, competition from larger industrial technology firms is a constant threat. Valuation risk is currently the most severe given the stock's price level.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $225 and $245, as it meets analyst EPS estimates of $9.91 with stable valuation multiples. The Bull Case (25% probability) targets $255 to $270 on strong execution and multiple expansion, breaking above the 52-week high. The Bear Case (15% probability) warns of a drop to $190-$210 on growth deceleration and multiple compression. The Base Case is most likely, implying modest single-digit returns from the current price, heavily dependent on the company hitting its growth targets without any missteps.
Based on traditional metrics, AME appears overvalued relative to the broader industrial sector but may be fairly valued relative to its own exceptional quality. Its forward P/E of 25.96x and PEG ratio of 4.05 are significantly higher than typical sector averages. However, this premium is supported by superior profitability metrics like a 26.2% operating margin and 20.0% net margin. The valuation implies the market expects Ametek to continue its high-single to low-double-digit growth with stable margins indefinitely. Any deviation from this perfect execution path could lead to multiple compression.
AME is a good stock to own, but timing the purchase is critical. For long-term investors with a multi-year horizon, AME represents a high-quality compounder with a proven track record. However, at its current price of $228.76 and forward P/E of 25.96x, the stock is fairly valued to slightly overvalued, offering limited near-term upside and a potential 24% downside to its 52-week low if sentiment sours. It would be a more compelling buy on a market-driven pullback towards the $200-$210 range, which would improve the risk/reward profile significantly.
AME is unequivocally suitable for long-term investment, with a suggested minimum holding period of 3-5 years. Its business model as a compounder of capital through niche market leadership and acquisitions rewards patient investors. The stock's beta of 1.033 means it carries typical market volatility, making it less ideal for short-term trading, especially given its current valuation near resistance. Long-term investors can benefit from its durable competitive advantages, consistent free cash flow generation, and shareholder-friendly capital allocation (dividend growth, buybacks), which can smooth out short-term price fluctuations driven by valuation concerns.